Published in J Virol on September 01, 1989
Retargeting of coronavirus by substitution of the spike glycoprotein ectodomain: crossing the host cell species barrier. J Virol (2000) 3.46
Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol Mol Biol Rev (2005) 3.18
A system for study of coronavirus mRNA synthesis: a regulated, expressed subgenomic defective interfering RNA results from intergenic site insertion. J Virol (1991) 2.30
Subgenomic RNA synthesis directed by a synthetic defective interfering RNA of mouse hepatitis virus: a study of coronavirus transcription initiation. J Virol (1994) 1.85
Analysis of a recombinant mouse hepatitis virus expressing a foreign gene reveals a novel aspect of coronavirus transcription. J Virol (1997) 1.77
Genetics of mouse hepatitis virus transcription: evidence that subgenomic negative strands are functional templates. J Virol (1994) 1.72
An in vitro system for the leader-primed transcription of coronavirus mRNAs. EMBO J (1990) 1.69
Coronavirus leader RNA regulates and initiates subgenomic mRNA transcription both in trans and in cis. J Virol (1994) 1.58
Murine coronavirus nonstructural protein ns2 is not essential for virus replication in transformed cells. J Virol (1990) 1.57
Single-amino-acid substitutions in open reading frame (ORF) 1b-nsp14 and ORF 2a proteins of the coronavirus mouse hepatitis virus are attenuating in mice. J Virol (2005) 1.54
Mutagenic analysis of the coronavirus intergenic consensus sequence. J Virol (1992) 1.45
Requirement of the 5'-end genomic sequence as an upstream cis-acting element for coronavirus subgenomic mRNA transcription. J Virol (1994) 1.41
Regulation of coronavirus mRNA transcription. J Virol (1995) 1.40
The UCUAAAC promoter motif is not required for high-frequency leader recombination in bovine coronavirus defective interfering RNA. J Virol (1996) 1.35
Polypyrimidine tract-binding protein binds to the leader RNA of mouse hepatitis virus and serves as a regulator of viral transcription. J Virol (1999) 1.28
Mouse hepatitis virus S RNA sequence reveals that nonstructural proteins ns4 and ns5a are not essential for murine coronavirus replication. J Virol (1991) 1.25
The receptor for mouse hepatitis virus in the resistant mouse strain SJL is functional: implications for the requirement of a second factor for viral infection. J Virol (1992) 1.22
Unusual heterogeneity of leader-mRNA fusion in a murine coronavirus: implications for the mechanism of RNA transcription and recombination. J Virol (1994) 1.21
Interactions between the cytoplasmic proteins and the intergenic (promoter) sequence of mouse hepatitis virus RNA: correlation with the amounts of subgenomic mRNA transcribed. J Virol (1995) 1.21
Evidence for coronavirus discontinuous transcription. J Virol (1994) 1.20
Assembled coronavirus from complementation of two defective interfering RNAs. J Virol (1997) 1.18
Structure, function and evolution of the hemagglutinin-esterase proteins of corona- and toroviruses. Glycoconj J (2006) 1.16
Infectious salmon anemia virus specifically binds to and hydrolyzes 4-O-acetylated sialic acids. J Virol (2004) 1.13
Identification of a coronavirus hemagglutinin-esterase with a substrate specificity different from those of influenza C virus and bovine coronavirus. J Virol (1999) 1.12
Antisense morpholino-oligomers directed against the 5' end of the genome inhibit coronavirus proliferation and growth. J Virol (2004) 1.09
Map locations of mouse hepatitis virus temperature-sensitive mutants: confirmation of variable rates of recombination. J Virol (1994) 1.08
Coronavirus mRNA transcription: UV light transcriptional mapping studies suggest an early requirement for a genomic-length template. J Virol (1992) 1.07
Suppression of coronavirus replication by inhibition of the MEK signaling pathway. J Virol (2006) 1.01
The hemagglutinin-esterase of mouse hepatitis virus strain S is a sialate-4-O-acetylesterase. J Virol (1999) 1.01
Pathogenesis of murine coronavirus in the central nervous system. J Neuroimmune Pharmacol (2010) 0.99
Expression of hemagglutinin esterase protein from recombinant mouse hepatitis virus enhances neurovirulence. J Virol (2005) 0.95
Luxury at a cost? Recombinant mouse hepatitis viruses expressing the accessory hemagglutinin esterase protein display reduced fitness in vitro. J Virol (2005) 0.94
Two murine coronavirus genes suffice for viral RNA synthesis. J Virol (1995) 0.93
Function of a 5'-end genomic RNA mutation that evolves during persistent mouse hepatitis virus infection in vitro. J Virol (1995) 0.93
Hemagglutinin-esterase-specific monoclonal antibodies alter the neuropathogenicity of mouse hepatitis virus. J Virol (1992) 0.90
The leader RNA of coronavirus mouse hepatitis virus contains an enhancer-like element for subgenomic mRNA transcription. J Virol (2000) 0.89
Role of mouse hepatitis virus (MHV) receptor murine CEACAM1 in the resistance of mice to MHV infection: studies of mice with chimeric mCEACAM1a and mCEACAM1b. J Virol (2010) 0.85
A 5'-proximal RNA sequence of murine coronavirus as a potential initiation site for genomic-length mRNA transcription. J Virol (1996) 0.82
High-Resolution Analysis of Coronavirus Gene Expression by RNA Sequencing and Ribosome Profiling. PLoS Pathog (2016) 0.78
New nucleotide sequence data on the EMBL File Server. Nucleic Acids Res (1989) 0.75
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol (1980) 287.68
A simple and very efficient method for generating cDNA libraries. Gene (1983) 55.36
A bacteriophage T7 RNA polymerase/promoter system for controlled exclusive expression of specific genes. Proc Natl Acad Sci U S A (1985) 46.59
Supercoil sequencing: a fast and simple method for sequencing plasmid DNA. DNA (1985) 40.01
An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res (1987) 36.83
Prolonged incubation in calcium chloride improves the competence of Escherichia coli cells. Gene (1979) 25.53
3'-terminal nucleotide sequence of encephalomyocarditis virus RNA determined by reverse transcriptase and chain-terminating inhibitors. Proc Natl Acad Sci U S A (1978) 6.67
Extraction of nucleic acids from agarose gels. Anal Biochem (1980) 6.38
RNA of mouse hepatitis virus. J Virol (1978) 4.27
Mouse hepatitis virus A59: mRNA structure and genetic localization of the sequence divergence from hepatotropic strain MHV-3. J Virol (1981) 4.00
Characterization of leader RNA sequences on the virion and mRNAs of mouse hepatitis virus, a cytoplasmic RNA virus. Proc Natl Acad Sci U S A (1984) 3.81
Coronavirus mRNA synthesis involves fusion of non-contiguous sequences. EMBO J (1983) 3.13
Regulation of protein synthesis in virus-infected animal cells. Adv Virus Res (1986) 2.93
I. Structural proteins: effects of preparative conditions on the migration of protein in polyacrylamide gels. Virology (1977) 2.87
Completion of the sequence of the genome of the coronavirus avian infectious bronchitis virus. J Gen Virol (1987) 2.84
Sequence of mouse hepatitis virus A59 mRNA 2: indications for RNA recombination between coronaviruses and influenza C virus. Virology (1988) 2.83
Characterization of replicative intermediate RNA of mouse hepatitis virus: presence of leader RNA sequences on nascent chains. J Virol (1983) 2.80
Genomic RNA of the murine coronavirus JHM. J Gen Virol (1978) 2.78
Translation of three mouse hepatitis virus strain A59 subgenomic RNAs in Xenopus laevis oocytes. J Virol (1981) 2.69
A micromethod for detailed characterization of high molecular weight RNA. Methods Enzymol (1980) 2.36
Comparative analysis of RNA genomes of mouse hepatitis viruses. J Virol (1981) 2.30
The 5'-end sequence of the murine coronavirus genome: implications for multiple fusion sites in leader-primed transcription. Virology (1987) 2.17
Leader sequences of murine coronavirus mRNAs can be freely reassorted: evidence for the role of free leader RNA in transcription. Proc Natl Acad Sci U S A (1986) 2.16
Analysis of genomic and intracellular viral RNAs of small plaque mutants of mouse hepatitis virus, JHM strain. Virology (1984) 2.13
Structure of the intracellular defective viral RNAs of defective interfering particles of mouse hepatitis virus. J Virol (1985) 2.10
Characterization of leader-related small RNAs in coronavirus-infected cells: further evidence for leader-primed mechanism of transcription. Virus Res (1985) 2.07
Coronavirus JHM: intracellular protein synthesis. J Gen Virol (1981) 2.05
Bovine coronavirus structural proteins. J Virol (1982) 1.93
Sequence and translation of the murine coronavirus 5'-end genomic RNA reveals the N-terminal structure of the putative RNA polymerase. J Virol (1987) 1.89
Defective interfering particles of mouse hepatitis virus. Virology (1984) 1.76
Discontinuous transcription generates heterogeneity at the leader fusion sites of coronavirus mRNAs. J Virol (1988) 1.76
Analysis of intracellular small RNAs of mouse hepatitis virus: evidence for discontinuous transcription. Virology (1987) 1.52
Coronavirus JHM: coding assignments of subgenomic mRNAs. J Gen Virol (1983) 1.46
Evolution of the 5'-end of genomic RNA of murine coronaviruses during passages in vitro. Virology (1989) 1.43
Structural polypeptides of the murine coronavirus JHM. J Gen Virol (1979) 1.37
Coronavirus MHV-JHM mRNA 5 has a sequence arrangement which potentially allows translation of a second, downstream open reading frame. J Gen Virol (1985) 1.34
Nucleotide sequence of the gene encoding the surface projection glycoprotein of coronavirus MHV-JHM. J Gen Virol (1987) 1.32
Coronavirus leader-RNA-primed transcription: an alternative mechanism to RNA splicing. Bioessays (1986) 1.12
RNA recombination of coronaviruses: localization of neutralizing epitopes and neuropathogenic determinants on the carboxyl terminus of peplomers. Proc Natl Acad Sci U S A (1987) 1.11
Bovine coronavirus hemagglutinin protein. Virus Res (1985) 1.09
Characterization of small plaque mutants of mouse hepatitis virus, JHM strain. Microbiol Immunol (1983) 0.98
Temporal regulation of bovine coronavirus RNA synthesis. Virus Res (1988) 0.95
Haemagglutination by avian infectious bronchitis virus-a coronavirus. J Gen Virol (1975) 0.94
Characterization of a variant virus isolated from neural cell culture after infection of mouse coronavirus JHMV. Virology (1986) 0.89
Continuous tissue culture cell lines derived from chemically induced tumors of Japanese quail. Cell (1977) 7.23
Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science (1999) 6.21
Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu (1980) 5.03
Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nat Med (2000) 4.99
Mapping of sequences required for mouse neurovirulence of poliovirus type 2 Lansing. J Virol (1986) 4.91
A genetic determinant required for continuous reinfection of adjacent cells on large plasmid in S. flexneri 2a. Cell (1986) 4.88
NS3 is a serine protease required for processing of hepatitis C virus polyprotein. J Virol (1993) 4.60
DOCK 4.0: search strategies for automated molecular docking of flexible molecule databases. J Comput Aided Mol Des (2001) 4.54
Molecular cloning and sequencing of a human hepatitis delta (delta) virus RNA. Nature (1987) 4.52
Adenylic acid-rich sequence in RNAs of Rous sarcoma virus and Rauscher mouse leukaemia virus. Nature (1972) 4.49
Metabolic regulation of brain Abeta by neprilysin. Science (2001) 4.47
Molecular alteration of the 140-megadalton plasmid associated with loss of virulence and Congo red binding activity in Shigella flexneri. Infect Immun (1986) 4.33
RNA of mouse hepatitis virus. J Virol (1978) 4.27
The complete sequence (22 kilobases) of murine coronavirus gene 1 encoding the putative proteases and RNA polymerase. Virology (1991) 4.07
Assembly of recombinant TFIID reveals differential coactivator requirements for distinct transcriptional activators. Cell (1994) 4.06
Mouse hepatitis virus A59: mRNA structure and genetic localization of the sequence divergence from hepatotropic strain MHV-3. J Virol (1981) 4.00
Characterization of leader RNA sequences on the virion and mRNAs of mouse hepatitis virus, a cytoplasmic RNA virus. Proc Natl Acad Sci U S A (1984) 3.81
Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci (1995) 3.56
Human hepatitis delta virus RNA subfragments contain an autocleavage activity. Proc Natl Acad Sci U S A (1989) 3.51
Avian tumor virus RNA: a comparison of three sarcoma viruses and their transformation-defective derivatives by oligonucleotide fingerprinting and DNA-RNA hybridization. Proc Natl Acad Sci U S A (1973) 3.46
Ribonucleic acid components of murine sarcoma and leukemia viruses. Proc Natl Acad Sci U S A (1973) 3.42
Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology (2001) 3.40
virG, a plasmid-coded virulence gene of Shigella flexneri: identification of the virG protein and determination of the complete coding sequence. J Bacteriol (1989) 3.31
Virulence-associated genetic regions comprising 31 kilobases of the 230-kilobase plasmid in Shigella flexneri 2a. J Bacteriol (1988) 3.24
Biosynthesis and biochemical properties of the hepatitis C virus core protein. J Virol (1994) 3.19
Glass fiber contamination of cigarette filters: an additional health risk to the smoker? Cancer Epidemiol Biomarkers Prev (1998) 3.15
Human hepatitis delta antigen is a nuclear phosphoprotein with RNA-binding activity. J Virol (1988) 3.11
The NOD mouse: recessive diabetogenic gene in the major histocompatibility complex. Science (1986) 3.09
Presence of leader sequences in the mRNA of mouse hepatitis virus. J Virol (1983) 3.06
High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol (2001) 3.06
Binding of TAFs to core elements directs promoter selectivity by RNA polymerase II. Cell (1995) 3.01
High-frequency RNA recombination of murine coronaviruses. J Virol (1986) 2.91
Replication of mouse hepatitis virus: negative-stranded RNA and replicative form RNA are of genome length. J Virol (1982) 2.86
Urachal remnant diseases: spectrum of CT and US findings. Radiographics (2001) 2.82
Specification of kinetochore-forming chromatin by the histone H3 variant CENP-A. J Cell Sci (2001) 2.82
A dual transcriptional activation system for the 230 kb plasmid genes coding for virulence-associated antigens of Shigella flexneri. Mol Microbiol (1989) 2.81
Identification of CTX-M-14 extended-spectrum beta-lactamase in clinical isolates of Shigella sonnei, Escherichia coli, and Klebsiella pneumoniae in Korea. J Clin Microbiol (2001) 2.80
The murine autoimmune diabetes model: NOD and related strains. Adv Immunol (1992) 2.80
Characterization of replicative intermediate RNA of mouse hepatitis virus: presence of leader RNA sequences on nascent chains. J Virol (1983) 2.80
Circadian waves of expression of the APRR1/TOC1 family of pseudo-response regulators in Arabidopsis thaliana: insight into the plant circadian clock. Plant Cell Physiol (2000) 2.61
Structure of a cephalosporin synthase. Nature (1998) 2.59
Drosophila TAFII150: similarity to yeast gene TSM-1 and specific binding to core promoter DNA. Science (1994) 2.48
Characterization of two RNA polymerase activities induced by mouse hepatitis virus. J Virol (1982) 2.46
Retained asymptomatic third molars and risk for second molar pathology. J Dent Res (2013) 2.43
Enzymic parameters: measurement of V and Km. Biochim Biophys Acta (1971) 2.42
Molecular characterization of proteins in detergent solutions. Biochemistry (1974) 2.36
The 3'-untranslated region of hepatitis C virus RNA enhances translation from an internal ribosomal entry site. J Virol (1998) 2.36
A mouse model for poliovirus neurovirulence identifies mutations that attenuate the virus for humans. J Virol (1987) 2.36
Further characterization of mRNA's of mouse hepatitis virus: presence of common 5'-end nucleotides. J Virol (1982) 2.34
Hepatitis C virus RNA polymerase and NS5A complex with a SNARE-like protein. Virology (1999) 2.33
Abietadiene synthase from grand fir (Abies grandis): characterization and mechanism of action of the "pseudomature" recombinant enzyme. Biochemistry (2000) 2.31
Airway hyperresponsiveness, increased intracellular spaces of bronchial epithelium, and increased infiltration of eosinophils and lymphocytes in bronchial mucosa in asthma. Am Rev Respir Dis (1992) 2.30
Comparative analysis of RNA genomes of mouse hepatitis viruses. J Virol (1981) 2.30
Restriction enzyme sites on the avian RNA tumor virus genome. J Virol (1978) 2.29
Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J Virol (1998) 2.28
Determination of the secondary structure of and cellular protein binding to the 3'-untranslated region of the hepatitis C virus RNA genome. J Virol (1997) 2.28
Cataract in leprosy patients: cataract surgical coverage, barriers to acceptance of surgery, and outcome of surgery in a population based survey in Korea. Br J Ophthalmol (2001) 2.22
DNA sequence and product analysis of the virF locus responsible for congo red binding and cell invasion in Shigella flexneri 2a. Infect Immun (1986) 2.22
Occurrence of partial deletion and substitution of the src gene in the RNA genome of avian sarcoma virus. Proc Natl Acad Sci U S A (1977) 2.22
Recombination between nonsegmented RNA genomes of murine coronaviruses. J Virol (1985) 2.21
Ectopic expression of activated Stat6 induces the expression of Th2-specific cytokines and transcription factors in developing Th1 cells. Immunity (1999) 2.21
Electron microscope heteroduplex studies of sequence relations among plasmids of Escherichia coli. VII. Mapping the ribosomal RNA genes of plasmid F14. J Mol Biol (1974) 2.18
The 5'-end sequence of the murine coronavirus genome: implications for multiple fusion sites in leader-primed transcription. Virology (1987) 2.17
Characterization of hepatitis delta antigen: specific binding to hepatitis delta virus RNA. J Virol (1990) 2.17
Leader sequences of murine coronavirus mRNAs can be freely reassorted: evidence for the role of free leader RNA in transcription. Proc Natl Acad Sci U S A (1986) 2.16
A recombinant hepatitis C virus RNA-dependent RNA polymerase capable of copying the full-length viral RNA. J Virol (1999) 2.16
Analysis of genomic and intracellular viral RNAs of small plaque mutants of mouse hepatitis virus, JHM strain. Virology (1984) 2.13
Antigenic relationships of murine coronaviruses: analysis using monoclonal antibodies to JHM (MHV-4) virus. Virology (1983) 2.11
Electron microscope heteroduplex studies of sequence relations among plasmids of Escherichia coli. IV. The F sequences in F14. J Mol Biol (1974) 2.11
Structure of the intracellular defective viral RNAs of defective interfering particles of mouse hepatitis virus. J Virol (1985) 2.10
Promotion of spontaneous diabetes in non-obese diabetes-prone mice by cyclophosphamide. Diabetologia (1984) 2.07
Phosphoproteins of murine hepatitis viruses. J Virol (1979) 2.07
Characterization of leader-related small RNAs in coronavirus-infected cells: further evidence for leader-primed mechanism of transcription. Virus Res (1985) 2.07
Molecular cloning of a genetic determinant for Congo red binding ability which is essential for the virulence of Shigella flexneri. Infect Immun (1986) 2.05
Retracted New findings of the correlation between acupoints and corresponding brain cortices using functional MRI. Proc Natl Acad Sci U S A (1998) 2.05
Identification and characterization of a coronavirus packaging signal. J Virol (1992) 2.01
Identification of a novel gene, dep, associated with depolymerization of the capsular polymer in Bacillus anthracis. Mol Microbiol (1993) 1.96
High-frequency leader sequence switching during coronavirus defective interfering RNA replication. J Virol (1989) 1.95
Double termination of the alimentary tract in females: a report of 12 cases and a literature review. J Pediatr Surg (1984) 1.90
An internal polypyrimidine-tract-binding protein-binding site in the hepatitis C virus RNA attenuates translation, which is relieved by the 3'-untranslated sequence. Virology (1999) 1.90
Characterization of the coronavirus M protein and nucleocapsid interaction in infected cells. J Virol (2000) 1.89
Sequence and translation of the murine coronavirus 5'-end genomic RNA reveals the N-terminal structure of the putative RNA polymerase. J Virol (1987) 1.89
Analysis of cis-acting sequences essential for coronavirus defective interfering RNA replication. Virology (1993) 1.89
Analysis of efficiently packaged defective interfering RNAs of murine coronavirus: localization of a possible RNA-packaging signal. J Virol (1990) 1.88
Primary structure and translation of a defective interfering RNA of murine coronavirus. Virology (1988) 1.87
Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor. J Virol (1997) 1.84
Identification of a domain required for autoproteolytic cleavage of murine coronavirus gene A polyprotein. J Virol (1989) 1.82
Isolation, characterization, and mapping of Tn5 insertions into the 140-megadalton invasion plasmid defective in the mouse Sereny test in Shigella flexneri 2a. Infect Immun (1986) 1.81
The binding of deoxycholate and Triton X-100 to proteins. J Biol Chem (1973) 1.81